Highstreet Asset Management Inc. acquired a new stake in shares of Humana Inc. (NYSE:HUM) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 2,910 shares of the insurance provider’s stock, valued at approximately $701,000.

A number of other hedge funds have also added to or reduced their stakes in HUM. Guardian Life Insurance Co. of America raised its stake in Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock valued at $119,000 after buying an additional 4 shares in the last quarter. Independent Portfolio Consultants Inc. raised its stake in Humana by 22.1% in the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock valued at $125,000 after buying an additional 94 shares in the last quarter. Point72 Asia Hong Kong Ltd acquired a new stake in Humana during the first quarter valued at about $128,000. Westbourne Investment Advisors Inc. acquired a new stake in Humana during the second quarter valued at about $205,000. Finally, Hengehold Capital Management LLC acquired a new stake in Humana during the second quarter valued at about $209,000. Hedge funds and other institutional investors own 99.13% of the company’s stock.

Shares of Humana Inc. (NYSE HUM) opened at 247.66 on Friday. Humana Inc. has a 12 month low of $163.50 and a 12 month high of $255.27. The company’s 50-day moving average price is $240.83 and its 200-day moving average price is $224.23. The firm has a market cap of $35.79 billion, a P/E ratio of 20.37 and a beta of 0.91.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, beating analysts’ consensus estimates of $3.08 by $0.41. The firm had revenue of $13.53 billion during the quarter, compared to analyst estimates of $13.61 billion. Humana had a net margin of 3.37% and a return on equity of 15.85%. During the same period in the previous year, the business earned $2.30 EPS. On average, analysts predict that Humana Inc. will post $11.55 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Tuesday, August 29th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.65%. Humana’s dividend payout ratio (DPR) is currently 13.06%.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another domain, it was illegally copied and republished in violation of United States & international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2017/08/18/2910-shares-in-humana-inc-hum-acquired-by-highstreet-asset-management-inc.html.

Several analysts have issued reports on the company. Zacks Investment Research upgraded Humana from a “hold” rating to a “buy” rating and set a $253.00 price objective on the stock in a research note on Thursday, May 18th. BidaskClub lowered Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, June 13th. Citigroup Inc. assumed coverage on Humana in a research note on Wednesday, June 28th. They issued a “buy” rating and a $275.00 price objective on the stock. Credit Suisse Group restated an “outperform” rating and issued a $260.00 price objective (up previously from $250.00) on shares of Humana in a research note on Thursday, August 3rd. Finally, Deutsche Bank AG upped their price objective on Humana from $234.00 to $243.00 and gave the company a “hold” rating in a research note on Monday, August 7th. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and twelve have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $244.35.

In other news, CEO Bruce D. Broussard sold 12,000 shares of the business’s stock in a transaction on Friday, August 11th. The shares were sold at an average price of $251.88, for a total transaction of $3,022,560.00. Following the completion of the transaction, the chief executive officer now directly owns 80,086 shares in the company, valued at approximately $20,172,061.68. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP M Todoroff Christopher sold 22,935 shares of the business’s stock in a transaction on Thursday, August 10th. The shares were sold at an average price of $252.52, for a total transaction of $5,791,546.20. Following the transaction, the vice president now owns 24,001 shares of the company’s stock, valued at $6,060,732.52. The disclosure for this sale can be found here. Insiders have sold a total of 41,406 shares of company stock valued at $10,355,086 over the last 90 days. Company insiders own 0.80% of the company’s stock.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.